Association Analysis of Age Acceleration and Cardiovascular Diseases
Technology Platforms & Expertise
Online Inquiry

Association Analysis of Age Acceleration and Cardiovascular Diseases


Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide, with age being a significant risk factor for the development and progression of these conditions. As individuals age, their risk of developing CVD increases due to various physiological changes in the cardiovascular system. DNA methylation age acceleration, which refers to the discrepancy between an individual's chronological age and their biological age, has been shown to play a role in the pathogenesis of CVD. CD BioSciences helps clients conduct association studies of DNA methylation age acceleration and cardiovascular diseases to investigate the relationship between aging and cardiovascular health.

Types of Cardiovascular Diseases Associated With Age Acceleration That We Analyze

At CD BioSciences, we assist our clients in conducting association studies to investigate the relationship between DNA methylation age acceleration and different types of cardiovascular diseases. Some of the CVDs that we analyze include:

  • Atherosclerosis. We investigate the accelerated aging processes that contribute to the development of atherosclerosis, elucidating the molecular and genetic factors that underpin this association.
  • Hypertension. Our analysis encompasses the intricate interplay between DNA methylation age acceleration and hypertension, shedding light on the biological mechanisms that predispose individuals to elevated blood pressure as they age.
  • Heart failure. We explore the impacts of DNA methylation age acceleration on the pathogenesis of heart failure, dissecting the molecular processes that culminate in cardiac dysfunction associated with aging.
  • Stroke. Our studies encompass an in-depth analysis of age-related factors that contribute to an increased risk of stroke, providing valuable insights into the interconnections between aging and cerebrovascular events.

Our Association Analysis Services for Age Acceleration and Cardiovascular Diseases

  • DNA methylation age prediction
    We estimate DNA methylation age using appropriate algorithms or age prediction models, such as Hannum, Horvath, PhenoAge, and GrimAge clocks. These models are trained on large datasets and can predict an individual's age based on DNA methylation patterns.
  • DNA methylation age acceleration analysis
    We calculate age acceleration for each sample by comparing the estimated DNA methylation age with the chronological age of the individuals. Age acceleration represents the deviation of DNA methylation age from the chronological age.
  • Association analysis of age acceleration and cardiovascular disease
    We perform analysis to investigate the association between age acceleration and cardiovascular diseases. Our services involve grouping samples based on disease status (e.g., disease cases vs. controls) and comparing age acceleration between the groups.
  • Statistical analysis
    We apply appropriate statistical tests to assess the significance of the association between age acceleration and cardiovascular diseases. Commonly used tests include t-tests, chi-square tests, or regression models, depending on the nature of the data and research questions.

At CD BioSciences, our tireless efforts and expertise in researching the association between accelerated age and cardiovascular disease enable us to provide high-quality and comprehensive services. Upon completion of our association study, our clients can expect to receive a comprehensive report. Our deliverables are tailored and designed to provide reliable and meaningful insights. If you are interested in our services, please feel free to contact us or make an online inquiry.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.